PRojections In MUltiple Sclerosis (PRIMUS) is a precision medicine platform project in multiple sclerosis (MS) based on the reuse of clinical research data for clinical decision support.
It is led by a consortium of academic, IT, and pharmaceutical companies and supported in part by the French National Research Agency (Agence Nationale de la Recherche, ANR) as its 3rd PIA, integrated to France 2030 plan under reference [ANR-21-RHUS-0014].
See the official project description by the Rennes University Hospital.
MS is a chronic autoimmune disease of the central nervous system (brain + spinal cord) affecting 2-3 Millions people worldwide. Numerous disease modifying treatments are approved on the market. Yet, disease activity, progression, and therapeutic responses are highly variable, calling for precision medicine.
The PRIMUS platform aims at providing neurologists and neuroradiologists several modules to support precision medicine along the whole MS care pathway.
- A brain MRI viewer with AI-powered lesion segmentation and counting
- A clinical decision support system for treatment selection based on the visualization of similar patients data
